27613895|t|Examination of the Involvement of Cholinergic - Associated Genes in Nicotine Behaviors in European and African Americans
27613895|a|Cigarette smoking is a physiologically harmful habit. Nicotinic acetylcholine receptors (nAChRs) are bound by nicotine and upregulated in response to chronic exposure to nicotine. It is known that upregulation of these receptors is not due to a change in mRNA of these genes, however, more precise details on the process are still uncertain, with several plausible hypotheses describing how nAChRs are upregulated. We have manually curated a set of genes believed to play a role in nicotine - induced nAChR upregulation. Here, we test the hypothesis that these genes are associated with and contribute risk for nicotine dependence (ND) and the number of cigarettes smoked per day (CPD). Studies with genotypic data on European and African Americans (EAs and AAs, respectively) were collected and a gene-based test was run to test for an association between each gene and ND and CPD. Although several novel genes were associated with CPD and ND at P < 0.05 in EAs and AAs, these associations did not survive correction for multiple testing. Previous associations between CHRNA3, CHRNA5, CHRNB4 and CPD in EAs were replicated. Our hypothesis-driven approach avoided many of the limitations inherent in pathway analyses and provided nominal evidence for association between cholinergic-related genes and nicotine behaviors. We evaluated the evidence for association between a manually curated set of genes and nicotine behaviors in European and African Americans. Although no genes were associated after multiple testing correction, this study has several strengths: by manually curating a set of genes we circumvented the limitations inherent in many pathway analyses and tested several genes that had not yet been examined in a human genetic study; gene-based tests are a useful way to test for association with a set of genes; and these genes were collected based on literature review and conversations with experts, highlighting the importance of scientific collaboration.
27613895	0	11	Examination	T058	C0220825
27613895	19	30	Involvement	T169	C1314939
27613895	34	45	Cholinergic	T169	C0599668
27613895	48	58	Associated	T080	C0439849
27613895	59	64	Genes	T028	C0017337
27613895	68	76	Nicotine	T109,T131	C0028040
27613895	77	86	Behaviors	T053	C0004927
27613895	90	98	European	T098	C0683983
27613895	103	120	African Americans	T098	C0085756
27613895	121	138	Cigarette smoking	T055	C0700219
27613895	144	159	physiologically	T169	C0205463
27613895	160	173	harmful habit	UnknownType	C0679788
27613895	175	208	Nicotinic acetylcholine receptors	T116,T192	C0034830
27613895	210	216	nAChRs	T116,T192	C0034830
27613895	222	230	bound by	T082	C0332297
27613895	231	239	nicotine	T109,T131	C0028040
27613895	244	255	upregulated	T044	C0949479
27613895	271	278	chronic	T079	C0205191
27613895	279	290	exposure to	T080	C0332157
27613895	291	299	nicotine	T109,T131	C0028040
27613895	318	330	upregulation	T044	C0949479
27613895	340	349	receptors	T116,T192	C0597357
27613895	376	380	mRNA	T114,T123	C0035696
27613895	390	395	genes	T028	C0017337
27613895	476	496	plausible hypotheses	T078	C1512571
27613895	512	518	nAChRs	T116,T192	C0034830
27613895	523	534	upregulated	T044	C0949479
27613895	544	560	manually curated	T052	C1707535
27613895	570	575	genes	T028	C0017337
27613895	603	611	nicotine	T109,T131	C0028040
27613895	614	621	induced	T169	C0205263
27613895	622	627	nAChR	T116,T192	C0034830
27613895	628	640	upregulation	T044	C0949479
27613895	660	670	hypothesis	T078	C1512571
27613895	682	687	genes	T028	C0017337
27613895	692	707	associated with	T080	C0332281
27613895	723	727	risk	T078	C0035647
27613895	732	751	nicotine dependence	T048	C0028043
27613895	753	755	ND	T048	C0028043
27613895	765	800	number of cigarettes smoked per day	T033	C0243095
27613895	802	805	CPD	T033	C0243095
27613895	808	815	Studies	T062	C2603343
27613895	821	830	genotypic	T032	C0017431
27613895	831	835	data	T078	C1511726
27613895	839	847	European	T098	C0683983
27613895	852	869	African Americans	T098	C0085756
27613895	871	874	EAs	T098	C0683983
27613895	879	882	AAs	T098	C0683983
27613895	919	934	gene-based test	T170	C0392366
27613895	946	950	test	T169	C0039593
27613895	958	969	association	T080	C0439849
27613895	983	987	gene	T028	C0017337
27613895	992	994	ND	T048	C0028043
27613895	999	1002	CPD	T033	C0243095
27613895	1021	1026	novel	T080	C0205314
27613895	1027	1032	genes	T028	C0017337
27613895	1038	1053	associated with	T080	C0332281
27613895	1054	1057	CPD	T033	C0243095
27613895	1062	1064	ND	T048	C0028043
27613895	1080	1083	EAs	T098	C0683983
27613895	1088	1091	AAs	T098	C0683983
27613895	1099	1111	associations	T080	C0439849
27613895	1116	1119	not	T169	C1518422
27613895	1128	1138	correction	T169	C1947976
27613895	1143	1159	multiple testing	T169	C0039593
27613895	1170	1182	associations	T080	C0439849
27613895	1191	1197	CHRNA3	T028	C1413403
27613895	1199	1205	CHRNA5	T028	C1413405
27613895	1207	1213	CHRNB4	T028	C1413410
27613895	1218	1221	CPD	T033	C0243095
27613895	1225	1228	EAs	T098	C0683983
27613895	1321	1337	pathway analyses	T170	C0868995
27613895	1351	1367	nominal evidence	T078	C3887511
27613895	1372	1383	association	T080	C0439849
27613895	1392	1411	cholinergic-related	T169	C0599668
27613895	1412	1417	genes	T028	C0017337
27613895	1422	1430	nicotine	T109,T131	C0028040
27613895	1431	1440	behaviors	T053	C0004927
27613895	1445	1454	evaluated	T058	C0220825
27613895	1459	1467	evidence	T078	C3887511
27613895	1472	1483	association	T080	C0439849
27613895	1494	1510	manually curated	T052	C1707535
27613895	1518	1523	genes	T028	C0017337
27613895	1528	1536	nicotine	T109,T131	C0028040
27613895	1537	1546	behaviors	T053	C0004927
27613895	1550	1558	European	T098	C0683983
27613895	1563	1580	African Americans	T098	C0683983
27613895	1591	1593	no	T033	C0205160
27613895	1594	1599	genes	T028	C0017337
27613895	1605	1615	associated	T080	C0439849
27613895	1622	1638	multiple testing	T169	C0039593
27613895	1639	1649	correction	T169	C1947976
27613895	1656	1661	study	T062	C2603343
27613895	1688	1705	manually curating	T052	C1707535
27613895	1715	1720	genes	T028	C0017337
27613895	1741	1752	limitations	T169	C0449295
27613895	1770	1786	pathway analyses	T170	C0868995
27613895	1791	1797	tested	T169	C0039593
27613895	1806	1811	genes	T028	C0017337
27613895	1848	1853	human	T016	C0086418
27613895	1854	1867	genetic study	T062	C2827447
27613895	1869	1885	gene-based tests	T170	C0392366
27613895	1906	1910	test	T169	C0039593
27613895	1915	1931	association with	T080	C0332281
27613895	1941	1946	genes	T028	C0017337
27613895	1958	1963	genes	T028	C0017337
27613895	1988	1998	literature	T170	C0023866
27613895	1999	2005	review	T169	C0699752
27613895	2010	2023	conversations	T054	C0871703
27613895	2029	2036	experts	T097	C1611835
27613895	2055	2065	importance	T080	C3898777
27613895	2069	2093	scientific collaboration	T054	C0282116